A 4052

  • New Jersey Assembly Bill
  • 2022-2023 Regular Session
  • Introduced in Assembly May 19, 2022
  • Passed Assembly Jun 30, 2023
  • Passed Senate Dec 21, 2023
  • Signed by Governor Jan 08, 2024

Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.*

Bill Subjects

Disease Health

Abstract

Bill Sponsors (29)

Votes


No votes to display

Actions


Jan 08, 2024

Governor of New Jersey

Approved P.L.2023, c.242.

Dec 21, 2023

Senate

Passed Senate (Passed Both Houses) (35-0)

Senate

Substituted for S2710 (1R)

Nov 30, 2023

Senate

Reported out of Senate Committee, 2nd Reading

Nov 27, 2023

Senate

Received in the Senate, Referred to Senate Budget and Appropriations Committee

Jun 30, 2023

Assembly

Passed Assembly (75-0-0)

Jun 22, 2023

Assembly

Reported out of Assembly Committee, 2nd Reading

Jun 05, 2023

Assembly

Reported out of Assembly Committee with Amendments and Referred to Assembly Appropriations Committee

May 19, 2022

Assembly

Introduced in the Assembly, Referred to Assembly Health Committee

Bill Text

Bill Text Versions Format
Introduced Version PDF HTML
Reprint AHE 6/5/23 1R PDF HTML

Related Documents

Document Format
Statement SBA 11/30/23
Statement AAP 6/22/23 1R
Statement AHE 6/5/23
Legislative Fiscal Estimate 6/26/23; 1R

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.